We want you to help us understand an important part of people's lives in the United States: how they think about who they are. We need your help to make our questions clearer. Your feedback will help us create better surveys for everyone. If you join the study, you will look at some draft questions and tell us what you think.

Do you have epilepsy and want exercise programs that suit you better? We're looking for adults with epilepsy, living in the U.S., to take part in a research study. You'll fill out a short, anonymous online survey about what you like in exercise programs and what makes staying active easy or hard for you. Plus, you'll have a chance to win one of five $50 Amazon gift cards.

We want to learn about how school-age children with hearing loss experience tiredness. We are asking caregivers to share their observations and experiences. This information will help us understand the challenges these children face and how to support them.

What if midlife women, who are inherently at an increased risk for future cardiometabolic disease due to transitioning into menopause, had access to a suite of evidence-based health interventions? Could these interventions reduce menopause-related inflammation, restore a healthier cardiometabolic profile, reverse epigenetic aging, and reduce bothersome menopausal symptoms? The ultimate goal of this work is to attenuate future disease and enhance women's quality of life, extend healthspan and increase productivity.

Are you due for a colonoscopy in the next 3 years? Has your doctor suggested a blood test called Shield to check for colon cancer? If you answered yes, you might be able to join a study to see how well the Shield test works compared to a colonoscopy.

Are you feeling a lack of interest in your hobbies, overwhelmed, or disconnected? If you are EITHER experiencing regular menstrual cycles OR more than a year from your last menstrual period, you may be able to participate in a research study to better understand the brain across the menopause transition. Compensation provided.

Do you have IgE mediated food allergies? Are you interested in the benefits of anti-IgE medications but are hoping to receive fewer injections? RPT904 is expected to work by blocking IgE antibodies, similar to a United States Food and Drug Administration (FDA) approved drug called omalizumab (available as Xolair® or generic omalizumab). However, RPT904 is designed to stay in the body longer than omalizumab and therefore require fewer injections.

We are currently recruiting for a new clinical trial investigating the feasibility of five days of personalized non-invasive brain stimulation for antenatal depression. In the first Phase of this study, we investigated this in healthy controls, and in the current phase, we are investigating this intervention in people with antenatal depression (depression during pregnancy). You will be compensated up to $600 for participation in the study, which includes a virtual screening, a baseline visit to measure high-density electroencephalography (HD-EEG), 5 consecutive in-person visits with stimulation over one week, one virtual follow up 2 weeks after the study, and a final virtual follow up 4-6 weeks after birth. We will then check your medical chart within 90 days of birth to review birth outcomes. If you are interested in participating in this study, you can fill out our pre-screening form to help us determine if you may be eligible.

We're looking to see if a new drug called zanidatamab, when used with chemotherapy, is safe and works well in treating early-stage HER2-positive breast cancer. If zanidatamab is effective, it might offer a better treatment option compared to the usual methods used today in battling this cancer type.

We're looking for people with bladder cancer to join a study on a new radiation treatment. If you have bladder cancer, this study will tests if receiving higher doses of radiation in a shorter time, along with chemotherapy, works as well as standard treatments. Participating may help you avoid surgery to remove your bladder. It may also mean you finish treatment faster, which might fit better with your needs. Overall, by joining the study you can contribute to improving future bladder cancer care for you and others.